Ted Skolarus to Medicare
This is a "connection" page, showing publications Ted Skolarus has written about Medicare.
Connection Strength
1.580
-
Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities. JCO Oncol Pract. 2023 05; 19(5):e763-e772.
Score: 0.173
-
Reframing Financial Incentives Around Reducing Readmission After Radical Cystectomy. Urology. 2020 08; 142:99-105.
Score: 0.143
-
Association Between Hospital Participation in Medicare Shared Savings Program Accountable Care Organizations and Readmission Following Major Surgery. Ann Surg. 2019 05; 269(5):873-878.
Score: 0.133
-
Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations. Cancer. 2018 08; 124(16):3364-3371.
Score: 0.125
-
Association of the Hospital Readmissions Reduction Program With Surgical Readmissions. JAMA Surg. 2018 03 01; 153(3):243-250.
Score: 0.123
-
Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care. Cancer. 2018 02 01; 124(3):563-570.
Score: 0.120
-
Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries. Urology. 2011 Dec; 78(6):1345-9.
Score: 0.079
-
Understanding prostate cancer spending growth among Medicare beneficiaries. Urology. 2011 Feb; 77(2):326-31.
Score: 0.075
-
Industry Payments to Urologists and Urologic Advanced Practice Providers in 2021. Urology. 2023 Oct; 180:121-129.
Score: 0.045
-
Evaluation of emergency department treat-and-release encounters after major gastrointestinal surgery. J Surg Oncol. 2023 Aug; 128(2):402-408.
Score: 0.044
-
Understanding Active Surveillance for Prostate Cancer. JCO Oncol Pract. 2021 11; 17(11):e1678-e1687.
Score: 0.038
-
Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees. Urology. 2021 09; 155:77-82.
Score: 0.038
-
Aligning Urology Residency Training With Real-World Workforce Needs. J Surg Educ. 2021 May-Jun; 78(3):820-827.
Score: 0.037
-
Resurrecting immortal-time bias in the study of readmissions. Health Serv Res. 2020 04; 55(2):273-276.
Score: 0.035
-
Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2020 06; 18(3):201-209.e2.
Score: 0.035
-
Adoption of Abiraterone and Enzalutamide by Urologists. Urology. 2019 09; 131:176-183.
Score: 0.033
-
Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer. Urol Oncol. 2019 07; 37(7):462-469.
Score: 0.033
-
Urologist Practice Structure and Spending for Prostate Cancer Care. Urology. 2019 Aug; 130:65-71.
Score: 0.033
-
Predictors and Cost of Readmission in Total Knee Arthroplasty. J Arthroplasty. 2018 09; 33(9):2759-2763.
Score: 0.031
-
Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer. Urology. 2018 06; 116:68-75.
Score: 0.031
-
Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly. Eur Urol. 2018 04; 73(4):491-498.
Score: 0.030
-
Sharp Decline In Prostate Cancer Treatment Among Men In The General Population, But Not Among Diagnosed Men. Health Aff (Millwood). 2017 01 01; 36(1):108-115.
Score: 0.028
-
Implications of evolving delivery system reforms for prostate cancer care. Am J Manag Care. 2016 Sep; 22(9):569-75.
Score: 0.028
-
Health Care Integration and Quality among Men with Prostate Cancer. J Urol. 2017 01; 197(1):55-60.
Score: 0.027
-
Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA. 2013 Jun 26; 309(24):2587-95.
Score: 0.022
-
Managed care and the diffusion of intensity-modulated radiotherapy for prostate cancer. Urology. 2012 Dec; 80(6):1236-42.
Score: 0.021
-
Health care reform in 2010: transforming the delivery system to improve quality of care. World J Urol. 2011 Feb; 29(1):85-90.
Score: 0.019